Brazilian hospital’s early action system prevents medication errors

Around the world / 06 April 2018

At the Hospital Estadual Sumaré, extra safety measures help avoid medication errors, and an ME-prevention method based on the principles of signal detection is being investigated.


The Hospital Estadual Sumaré (HES) is one of the hospitals of the University of Campinas (Unicamp), a public university in the state of São Paulo, Brazil. The hospital was opened in September 2000, and it is an important centre for education and in-service training for students from the School of Medical Sciences. 

HES was the first public hospital in Brazil to be certified with a higher grade in the Brazilian accreditation system for healthcare units, and the first hospital outside of the state capitals to be certified by the healthcare standards organisation Accreditation Canada, again at a higher level. Quality management is an important part of the hospital’s institutional culture. Following a recommendation by the regulatory authority of São Paulo, a pharmacovigilance commission was established in 2003 at the hospital, formed by a physician, a nurse, and a pharmacist. From the beginning, medication errors (MEs) were recognised as a specific issue that must be assessed separately from notifications related to suspected adverse drug reactions. Thus, several policies have been developed over the years, in order to reduce MEs at the hospital. 

For each phase of the medicine-handling process – starting with purchase of products, through storage, prescription, drug dispensing from pharmacists, and finally drug administration – there are certain actions and safety measures that must be taken. For example, the qualification of suppliers is checked at the purchasing phase; ‘high alert’ drugs such as adrenaline and anesthetics are marked with a red label in the storage phase, and medicines are also sorted in a colour scheme by expiration date; the prescription phase calls for the use of standard prescriptions made according to medical protocols; and so on.

One action in particular should be highlighted: the prescription system for antimicrobial prophylaxis in surgery. There is a prescription protocol, but the physicians’ rate of compliance with it was low – less than 50% – until 2011. The problem was that they were asked to prescribe using the drug name, but as doctors usually work in two or more hospitals and each institution has its own protocol, inconsistencies occurred. At HES, a system was created where the physicians should prescribe the name of the medical procedure instead, for example cholecystectomy, which resulted in 100% compliance with the protocol.

Colour coded medicines in the hospital pharmacy. Photo: Maurício Perroud

Colour coded medicines in the hospital pharmacy. Photo: Maurício Perroud

“HES staff are studying whether the methodology used to conduct signal detection in pharmacovigilance could be used for ‘signal detection’ to prevent medication errors in hospitals.”

Two years ago, staff at HES discussed the introduction of a method to identify a risk and take early action to prevent MEs. This question is relevant because the assessment of the database is usually done by analysing the most frequent events. Focusing on this point, a pilot study was conducted, which became a research project.

In this project – which is still ongoing – HES staff are studying whether the methodology used to conduct signal detection in pharmacovigilance – namely the proportional reporting ratio methodology – could be used for ‘signal detection’ to prevent MEs in hospitals. To apply this methodology, all adverse events of one sector, e.g. the internal medicine ward, are compared with all adverse events of the other sectors. The pilot study was undertaken in 2015 on data collected between 2013–2014 and it was possible to identify a ‘signal’ for MEs. Now this methodology is promoted at HES using a database with more than 5,400 adverse events, excluding suspected adverse drug reactions, reported since January 2008. If the validity of this process can be proved, HES will start a prospective study.

Maurício Perroud
Professor of Pneumology, School of Medical Sciences, Unicamp Medical Director, Hospital Estadual Sumaré, Unicamp

You may also like


ASCEND project’s success leads to a sharp rise in ADR reporting in Tanzania

The project epitomises the value of going digital and working together with each other and the community to strengthen pharmacovigilance systems.

Around the world / 25 September 2023

Strengthening pharmacovigilance systems in resource-limited countries

With the PAVIA project ending, participants identified what makes for a thriving pharmacovigilance system in countries burdened by poverty related diseases.

Around the world / 03 July 2023

Pharmacovigilance compliance among Marketing Authorisation holders in Saudi Arabia

The latest annual report of the SFDA reveals some interesting insights and next steps for pharmacovigilance compliance among MAHs.

Around the world / 07 August 2023

Our website uses cookies

Cookies are small text files held on your computer. They allow us to give you the best browsing experience possible and mean that we can understand how you use our site. Some cookies have already been set. You can delete and block cookies but parts of our site won't work without them. By using our website you accept our use of cookies.

Find out more